Cancer Stem Cells in Esophageal Squamous Cell Carcinoma: A Path to Understanding

Area of Science:

• Oncology
• Cancer Stem Cell Biology

Background:

• Esophageal squamous cell carcinoma (ESCC) is a prevalent cancer in developing nations with a dismal 5-year survival rate of 35%.
• Cancer stem cells (CSCs) are implicated as the primary drivers of ESCC initiation, progression, therapy resistance, and metastasis.
• Existing treatment modalities often fall short due to the inherent resistance mechanisms of CSCs.

Purpose of the Study:

• To comprehensively review the role of CSCs in ESCC.
• To explore the diagnostic and prognostic significance of CSC biomarkers in ESCC.
• To discuss the therapeutic potential of targeting CSCs and their associated biomarkers in ESCC.

Main Methods:

• Literature review of studies investigating CSCs in ESCC.
• Analysis of CSC characteristics, including enzymatic activity, surface markers, and drug resistance.
• Examination of the correlation between CSC biomarkers and clinical outcomes.

Main Results:

• CSC biomarkers offer valuable insights into ESCC prognosis, diagnosis, and treatment response.
• Multiconjugation of CSC markers enhances detection accuracy and treatment precision.
• Targeted therapies and immunotherapies based on CSCs hold promise for improved patient outcomes.

Conclusions:

• CSCs play a pivotal role in ESCC pathogenesis and treatment failure.
• Development of ESCC-specific CSC biomarkers is crucial for advancing targeted therapies and immunotherapies.
• A CSC-centric therapeutic strategy is essential for a holistic approach to managing ESCC.